Nigeria Neuropathic Pain Management Drugs Market, by Drug Class (Anticonvulsants, Serotonin–norepinephrine Reuptake Inhibitors (SNRIs), Tricyclic Antidepressants, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), and Others), by Disease Condition (Diabetic Neuropathy, Chemotherapy-induced Peripheral Neuropathy, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), is estimated to be valued at US$ 8.1 million in 2021 and is expected to exhibit a CAGR of 3.2% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.
Key players involved in the market are focusing on receiving product approvals from regulatory authorities and this is expected to drive the market growth over the forecast period.
For instance, in October 2017, Pfizer Inc., an American multinational pharmaceutical and biotechnology corporation, received the U.S. Food and Drug Administration (FDA) approval for LYRICA CR (pregabalin extended-release tablets) CV. It is approved as a once-daily therapy for the treatment of neuropathic pain related to diabetic peripheral neuropathy and for the treatment of postherpetic neuralgia, the most common complication of shingles (caused by herpes zoster virus). This condition causes long lasting burning pain after the rash has healed.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/4918
Damage to afferent nerve fibres in the spinal cord alters the transmission and transduction of information from the spinal cord to the brain. These fibres are prone to ectopic activity, which results in pain sensation in the numb area. They can also become hyperexcitable and irritable nociceptors. Because of the altered inputs, the nociceptive circuit receives increased calcium channel activity and enhanced synaptic transmission.
The pain that accompanies neuropathic disease is often difficult to treat with standard medication. There are several options for pain relief. Physical therapy, relaxation therapy, massage therapy, and medications are common options. Healthcare providers may recommend learning ways to cope with the pain, or teach patients techniques to sit, stand, or move. These therapies can all help to alleviate neuropathic pain. A multidisciplinary approach is crucial for treating this condition.
Nigeria Neuropathic Pain Management Drugs Market– Impact of Coronavirus (Covid-19) Pandemic
COVID-19 outbreak was first reported on December 31, 2019 in Wuhan, China. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 265,713,467 cases and 5,260,888 deaths due to Coronavirus (COVID-19) were reported up till December 07, 2021, across the globe.
The COVID-19 pandemic has significantly affected several markets across the globe and is also expected to make impact on the Nigeria neuropathic pain management drugs market. Neuropathic pain may be caused indirectly by SARS-CoV-2 or by COVID-19 after ICU treatment which mostly involves joint pain, muscle pain, and headache. The rise in COVID-19 cases is expected to increase prevalence of neuropathic pain.
Scarce local production of pain management drugs and problem of counterfeit drugs makes significant impact on the growth of the Nigerian neuropathic pain management drugs market. Fake medicine is harmful to the patient’s health. Hence, there is lucrative opportunity for development of advanced technologies in the Nigerian market to verify a product’s authentication before its sale.
Although it is difficult to cure neuropathic pain, research is finding ways to treat it effectively. Alternative therapy such as yoga and meditation have shown promising results. There is also evidence that some movement representation techniques, such as mirror therapy and motor imagery, can reduce pain and disability. However, further research is needed to understand the benefits of such therapies for neuropathic pain. Moreover, as long as treatment options are found, people can live a normal and healthy life.
We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/4918
Key Takeaways of the Nigeria Neuropathic Pain Management Drugs Market:
- The Nigeria neuropathic pain management drugs market is expected to exhibit a CAGR of 3.2% over the forecast period, owing to rising research and development activities to develop safe neuropathic management drugs
- Among drug class, tricyclic antidepressants segment is expected to account for largest market share during the forecast period, owing to rising prevalence of diabetic neuropathy. For instance, according to the International Diabetes Federation, in 2019, around 2,743,800 diabetes cases were registered in Nigeria. Diabetes leads to diabetic neuropathy, hence increasing diabetes incidence among the population is a major factor driving the market growth in Nigeria.
- Key players operating in the Nigeria neuropathic pain management drugs market include Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, and Biofemgroup Ltd.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Nigeria Neuropathic Pain Management Drugs Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Nigeria Neuropathic Pain Management Drugs Industry Impact
Chapter 2 Nigeria Neuropathic Pain Management Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Nigeria Neuropathic Pain Management Drugs (Volume and Value) by Type
2.3 Nigeria Neuropathic Pain Management Drugs (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Nigeria Neuropathic Pain Management Drugs Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 Company Profiles and Key Figures in Nigeria Neuropathic Pain Management Drugs Business
Chapter 6 Nigeria Neuropathic Pain Management Drugs Market Forecast (2022-2028)
Chapter 7 Conclusions
Direct Buy This Premium Research Report, Click Here Up to 25% OFF@ https://www.coherentmarketinsights.com/insight/buy-now/4918
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States
Phone: US +12067016702 / UK +4402081334027